This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Pfizer Inc. shed 4.1% to $22.88 on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.8% to 5,606.91 and Dow Jones Industrial Average falling 0.9% to 40,829.00.
This was the stock's second consecutive day of losses.
Pfizer Inc. closed 27.5% short of its 52-week high of $31.54, which the company achieved on July 30th.
The stock demonstrated a mixed performance when compared to some of its competitors, as Johnson & Johnson fell 0.3% to $154.47, Eli Lilly & Co. fell 5.6% to $775.12, and Abbott Laboratories rose 0.35% to $133.06.
Trading volume totaled 57.2 million, compared to the 50-day average of 55.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 06, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。